Rare diseases
Investigational molecules
Locations
279 conditions with trials, the busiest first
686 trials across Europe, recruiting first
A study testing molnupiravir in adults with COVID-19 who are not hospitalized and are at high risk for serious illness
BulgariaStudy on the Safety and Absorption of Meropenem and Vaborbactam in Children with Complicated Urinary Tract Infections
CzechiaTitle: Study of tianeptine effectiveness in treating cognitive symptoms (brain fog) in patients who have recovered from COVID-19
PolandStudy comparing aciclovir gel and cream effectiveness in treating recurrent cold sores (herpes labialis)
PolandA Study of ANX005 for Patients Recently Diagnosed with Guillain-Barré Syndrome to Evaluate How the Drug Works in the Body and Its Safety
DenmarkNon‑inferiority of fractional varicella zoster virus glycoprotein E vaccine (AS01B) versus recombinant varicella zoster virus glycoprotein E vaccine in adults with shingles
The NetherlandsStudy of the safety and immune response of gskvx000000077430 drug combination versus standard influenza vaccine in adults 18‑64 years
BelgiumEfficacy and safety of the investigational mRNA influenza vaccine gskvx000000077430 (drug combination) in adults ≥ 65 years
BelgiumSafety and Pharmacokinetics of MIB2 (StaphAcute) in Healthy Volunteers and Patients with Staphylococcus aureus Bacteremia
GermanyEffectiveness of mCOMBRIAX vaccine compared with high‑dose influenza vaccine and mRNA‑1273 in adults ≥65 years for prevention of influenza and COVID‑19
DenmarkDoxycycline post‑exposure prophylaxis for sexually transmitted infections in MSM and transgender women on antiretroviral drug combination
SpainCabotegravir and Rilpivirine Ultra‑Long‑Acting vs Long‑Acting in Adults and Adolescents with HIV Who Are Virally Suppressed
SpainThe therapies tested most often in Infections and infestations trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
